MHRA approves zuranolone to treat postnatal depression in adults following childbirth
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved zuranolone (brand name: Zurzuvae) to treat moderate or severe postnatal...
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved zuranolone (brand name: Zurzuvae) to treat moderate or severe postnatal...
DUBAI, UAE, Aug. 27, 2025 /PRNewswire/ -- XRP Healthcare today announced that its flagship XRPH AI App has been upgraded...
Belmont Behavioral Health, one of the Philadelphia area’s largest mental health providers, has been selected to the fill the gap...
In contrast, medication relieves ADHD symptoms such as hyperactivity and inattentiveness, with effects that wear off as the body breaks...
The postnatal depression (PND) treatment market is undergoing a seismic shift, driven by a confluence of societal awareness, regulatory advancements,...
A 101-year-old woman has shared her tips to a long and healthy life - and has revealed the surprising secret...
PEABODY — The city is partnering with a mental health app to support all residents and their families, especially students...
A global study of more than 100,000 young people has found that receiving a smartphone before age 13 is linked...
Introduction The healthcare industry has been undergoing a digital transformation, and 2025 is poised to be a landmark year for medical...